Today’s world is faced with a major increase in the number of chronic diseases. Why is this? An aging population, changes in lifestyle (nutrition, a sedentary lifestyle, etc.), but also medical progress which allows us to live longer with conditions which in the past could not be treated. Because a chronic disease lasts, it requires patients to learn how to live with it, permanently. Maintaining their independence and quality of life, and that of the people around them, therefore becomes an everyday challenge.
As a major world player in home healthcare, Air Liquide accompanies 1.7 million patients suffering from chronic diseases such as respiratory diseases, diabetes and Parkinson’s disease on a daily basis. Our approach: a personalized and patient-focused monitoring, coordinated with all healthcare professionals. The challenge: optimizing care from a therapeutic, organizational and economic point of view.
Our personalized care offering, coupled with digital solutions, takes into account parameters including physiological data, lifestyle and family circumstances to better meet patients’ needs. For example, Madeleine, who has been diabetic for many years, is visited by an Air Liquide home nurse, which has helped her to better control her insulin pump treatment. When she has questions, she can now contact expert nurses at any time via a helpline. Lastly, a connected monitor allows her blood glucose to be checked in real time and helps avoid unnecessary medical appointments. Her doctor is only notified in the event of a problem.
Drawing on its human, expert and technological approach, the Group thus contributes to the overall care of patients in their homes and plays a role in the wider coordination of players throughout the care pathway.
1 in 6
people in the world will be over the age of 65 by 2050(a).
60%
of people aged over 70 suffer from at least one chronic disease in industrialized countries(b).
In 2019 and at the beginning of 2020, Air Liquide pursued its development in Home Healthcare in Europe by broadening its range of services for diabetes patients in Germany, Belgium, the Netherlands and Luxembourg.
(a) United Nations - World Population Prospects 2019 - 2019.
(b) Stenholm S, Westerlund H, Head J et al. - Comorbidity and functional trajectories from midlife to old age: The Health and Retirement Study - 2014.
